Phosphorylation of c-Raf by Akt at S259, which was also blocked by the TPGS-YM155 concurrent treatment, inhibits activation of the Raf-MEK-ERK signalling pathway and shifts the cellular response from cell cycle arrest to proliferation in human breast cancer cells31. Here, RAF1 is linked to breast carcinoma.